Germany’s National genomDE Strategy | Nature Medicine

Here’s a ​breakdown of the affiliations‍ and authors, extracted from the ⁣provided HTML⁤ snippet:

* Stefan Froehling: ⁣(No specific affiliation listed beyond the initial ‍author‍ tag)
* Britta Haenisch: Center for ⁣Translational Medicine, University ‌of Bonn, Bonn, Germany; German Center for Neurodegenerative‍ Diseases (DZNE), Bonn, Germany
* ⁣ Andrea Hahne‌ & ⁤Daniel Hübschmann: BRCA Network-help for​ People affected by hereditary Cancer, Bonn, Germany
* Daniel Hübschmann: Innovation and Service Unit ‌for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute for Stem cell Technology ​and Experimental Medicine (HI-STEM), Heidelberg, Germany
* ​ ⁣ Heiko Krude: Institute of Experimental Pediatric endocrinology, Charite-Universitätsmedizin, Berlin, Germany
* Anna Lübu: Robert Koch Institute, Berlin, Germany
*​ Nisar Malek: Department for Internal ​Medicine 1, M3-Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tubingen, germany
* Nisar Malek, Yvonne‍ Möller, Stephan Ossowski & Oliver Kohlbacher: Center for Personalized‍ Medicine Tübingen, University Hospital Tübingen,‌ Tubingen, Germany
*‌ ‍ Christian ⁢Mertes: ​ TUM School of Computation, Details ‍and Technology, Technical University of Munich, Garching,‌ Germany; Institute of Human⁤ Genetics, School of Medicine, Technical University of Munich,​ Munich, Germany
* Yvonne Möller: ​M3-Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, tubingen, Germany
* Christine Mundlos: Alliance for Chronic Rare Diseases Germany (ACHSE), ‌DRK Klinikum ‌Berlin Mitte, Berlin, Germany
* Stephan Ossowski ​& Oliver Kohlbacher: Institute for Bioinformatics and ⁢Medical Informatics (IBMI), University⁢ of Tübingen, Tubingen, Germany
* ⁤ Faculty of Medicine, University of C (The affiliation is incomplete​ in the provided text)